The Florida Prescription Drug Monitoring Program, known as E-FORCSE® (Electronic-Florida Online Reporting of Controlled Substance Evaluation Program), was created by the 2009 Florida Legislature in an initiative to encourage safer prescribing of controlled substances and to reduce drug abuse and diversion within the state of Florida.

The Florida Prescription Drug Monitoring Program, known as E-FORCSE ® (Electronic-Florida Online Reporting of Controlled Substance Evaluation Program), was created by the 2009 Florida Legislature in an initiative to encourage safer prescribing of controlled substances and to reduce drug abuse and diversion within the state of Florida.

Non-Florida Licensed Registration Process for Federally Employed Prescribers and Dispensers

The Florida Department of Health works to protect, promote, and improve the health of all people in Florida through integrated state, county, and community efforts.

Florida’s prescription drug monitoring program (PDMP) has been in use since 2011, and it shares information with 29 states and the Military Health System. E-FORCSE® improves patient safety by: • Identifying patients who are obtaining opioids from multiple providers. • Calculating the total amount of opioids prescribed per day (in MME/day).

In the 2023 calendar year, the Florida PDMP Foundation continues to be an active force in support of the State of Florida Prescription Drug Monitoring Program (E-FORCSE® — the Electronic-Florida Online Reporting of Controlled Substances Evaluation).

Florida’s Prescription Drug Monitoring Program (PDMP) What healthcare providers should consider when prescribing controlled substances. What is a PDMP? The PDMP is a healthcare tool for clinicians to assist in identifying potential misuse, abuse or diversion of controlled substances by their patients while

The Florida Prescription Drug Monitoring Program, known as E-FORCSE® (Electronic-Florida Online Reporting of Controlled Substance Evaluation Program), was created by the 2009 Florida Legislature in an initiative to encourage safer prescribing of controlled substances and to reduce drug abuse and diversion within the state of Florida.

Chapter 893.055 established new guidelines for operating pain management clinics and approved development and utilization of a Prescription Drug Monitoring Program (“PDMP”) database to collect controlled substance prescription records from dispensers.

In accordance with Section 893.055 (3) (a), dispensers are required to report controlled substance dispensing information by the close of the next business day or have a Notification of Exemption from Reporting on file with Florida’s Prescription Drug Monitoring Program (PDMP), E-FORCSE®.